Pinsent Masons advises Zimmer MedizinSysteme GmbH on the acquisition of Enraf-Nonius B.V.

04 Nov 2021 | 12:22 pm | 1 min. read

Multinational law firm Pinsent Masons has advised Zimmer MedizinSysteme GmbH on the acquisition of Enraf-Nonius B.V., including interests in France and Thailand, from managing directors Len De Jong and Tom Doodkorte.

Drawing upon the expertise of a multi-jurisdictional and cross-practice team, Pinsent Masons provided advice around the structuring of the transaction, due diligence and negotiation of the contractual documentation.

Zimmer MedizinSysteme, based in Neu-Ulm, Germany, is a leading medical technology company in physical therapy, diagnostics and ultrasound, cold therapy and aesthetic medicine. The company, which has subsidiaries in the USA, China, France, Austria, and Belgium, employs 500 people worldwide and generates sales of almost 120 million euros.

Netherlands based Enraf-Nonius is a market leading global medical equipment and rehabilitation products company, generating annual sales of around 45 million euros.

The deal adds significant strength to Zimmer MedizinSysteme’s market share.

The Pinsent Masons team acting on the transaction was led by Sven Schulte-Hillen and Markus J. Friedl and included colleagues from the firm’s Frankfurt and Paris offices as well as it’s Amsterdam office (opened earlier this year).

Commenting on the deal, Sven Schulte Hillen said:

“We are pleased that Zimmer MedizinSysteme GmbH relied on our expertise for this novel and exciting project. This is the first time we have worked with them in relation to an M&A deal and we hope that we will continue to work with them in the future as they go from strength to strength in the med-tech market.

Armin Zimmer, managing director of Zimmer MedizinSysteme added:

“It was a pleasure to work with the Pinsent Masons Team. The responsible partners were always available for me and were at any time in full command of the transaction.“

Latest press releases

Show me all press releases

Pinsent Masons advises Arch Re on cross-border insurance business transfer

Multinational law firm Pinsent Masons has advised two subsidiaries of Arch Re – Southern Rock Insurance Company Limited (Southern Rock) and Alwyn Insurance Company Limited (Alwyn) – on the successful completion of an insurance business transfer under Part VII of the Financial Services and Markets Act 2000.

Pinsent Masons advises on acquisition of Alba Renewables

Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.

Pinsent Masons advises Aviva on Part VII transfer of former AIG Life protection business

Multinational law firm Pinsent Masons has advised the Aviva Group on the successful High Court-sanctioned transfer of the entire insurance business of Aviva Protection UK Limited (formerly AIG Life) to Aviva Life & Pensions UK Limited, under a Part VII insurance business transfer scheme.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises on acquisition of Alba Renewables

Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.

Pinsent Masons advises Great British Energy, National Wealth Fund and Scottish National Investment Bank on Pentland Investment

Multinational law firm Pinsent Masons has advised Great British Energy (“GBE”), the National Wealth Fund (“NWF”) and the Scottish National Investment Bank (“SNIB”) on their acquisition of a stake in Pentland Offshore Wind Farm from Copenhagen Infrastructure Partners (“CIP”) and agreed to provide an aggregate investment of up to £150,000,000 in the project.

Pinsent Masons advises Ufenau Capital Partners on its investment in Express Solicitors

Multinational law firm Pinsent Masons has advised Swiss-based Ufenau Capital Partners on its investment in Express Solicitors, a fast-growing UK personal injury law firm.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.